Biotech RadarJobs updated

COMPANY

Vitti Labs

vittilabs.com ↗

Clinical Phase 2

Profile checked Oct 10, 2026

Keywords: Pulmonary Fibrosis COVID-19 Respiratory Infection COVID-19 Acute Respiratory Distress Syndrome Respiratory Distress Syndrome Premature Ovarian Insufficiency Diminished Ovarian Reserve VL-PX10

3Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Cor source ↗
  2. Trial start Phase 1: A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI) source ↗
  3. Trial start Phase 2: Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 source ↗

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT05387239Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19Phase 2SuspendedNov 30, 20222024-11 (estimated)
NCT05387278Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)Phase 1SuspendedMar 20, 20252025-10 (estimated)
NCT06072794A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)Phase 1SuspendedOct 6, 20232025-10 (estimated)
Feedback